Description

Trizeptide Biovantage Labs Research Peptide

Trizeptide is a GLP-1/GIP/FGF21 tri-agonist research peptide studied for its multi-receptor metabolic signalling profile involving incretin pathways and fibroblast growth factor 21 receptor activation. Biovantage Labs supplies Trizeptide at 99+% purity, verified by batch-specific HPLC and Mass Spectrometry. Domestically fulfilled from Canada. Not for human consumption. Biovantage Labs provides this compound at 99+% purity, confirmed by batch-specific HPLC and Mass Spectrometry analysis, as a lyophilized compound for use in controlled laboratory settings.

Molecular Profile and Chemical Specifications

Specification	Detail
Classification	GLP-1 / GIP / FGF21 tri-agonist
Purity	≥99+% (HPLC/MS verified)
Physical Form	Lyophilized white powder

 

Primary Research Mechanisms

FGF21 Receptor Axis Activation

The FGF21 receptor component of Trizeptide’s profile is studied for its effects on hepatic fatty acid oxidation, adiponectin secretion, and brown adipose tissue activation mechanisms that are not engaged by GLP-1/GIP dual agonists and represent a distinct research axis.

Trizeptide is most informatively studied alongside Retatrutide in comparative multi-agonist research, both are tri-agonists sharing GLP-1 and GIP receptor engagement, with the third receptor axis (FGF21R in Trizeptide vs. glucagon receptor in Retatrutide) representing the primary experimental variable between them.

GLP-1 and GIP Incretin Co-Activation

Trizeptide incorporates GLP-1R and GIPR agonism, engaging the established incretin axes studied in glucose homeostasis and insulin secretion research. The addition of FGF21 receptor activity creates a research profile that bridges incretin and fibroblast growth factor signalling systems.

Comparative Multi-Agonist Research

Trizeptide serves as a research tool for comparative studies examining how FGF21 receptor co-activation modifies the metabolic outcomes of dual incretin agonism. Research in this area explores potential synergistic or additive effects across the three receptor systems.

Semaglutide provides the GLP-1-selective baseline in multi-agonist research designs, allowing the incremental contributions of GIP, FGF21R, and glucagon receptor co-activation to be isolated when compared against Trizeptide’s broader receptor profile.

Reconstitution Protocol

• Reconstitute using sterile bacteriostatic water or 0.9% sodium chloride solution
• Introduce diluent slowly along the interior vial wall do not inject directly onto the lyophilized cake
• Swirl gently until fully dissolved do not shake or vortex
• Allow the vial to equilibrate to room temperature before opening to prevent condensation

Storage and Stability

Storage Condition	State	Estimated Stability
-20°C to -80°C	Lyophilized	24+ months
2°C to 8°C	Lyophilized	12 months
Room temperature (20°C)	Lyophilized	3 months
2°C to 8°C	Reconstituted	7 to 14 days

 

Store in a desiccated environment away from UV exposure. Avoid repeated freeze-thaw cycles, which degrade peptide chain integrity over time.

Trizeptide Research FAQ

Q: How does Trizeptide differ from Retatrutide as a tri-agonist?

A: Both are tri-agonist research compounds, but they engage different third receptor axes. Retatrutide combines GLP-1, GIP, and glucagon receptor agonism. Trizeptide combines GLP-1, GIP, and FGF21 receptor agonism. The FGF21 versus glucagon distinction allows researchers to investigate the specific contributions of each receptor system.

Q: Is Trizeptide for human use?

A: No. Trizeptide supplied by Biovantage Labs is strictly for laboratory research purposes. It is not approved for human consumption, veterinary use, or clinical application.

Q: What purity standard does Biovantage Labs apply?

A: Every batch is verified at 99+% purity using HPLC to confirm compound concentration and Mass Spectrometry to confirm molecular identity. Batch-specific COA documentation is available upon request.

Q: Where does Biovantage Labs ship from?

A: All Biovantage Labs products are fulfilled domestically from within Canada, eliminating customs clearance risk and reducing transit time compared to international suppliers.